Dalaguite, Baby Boy B.

HRN: 27-76-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
CEFUROXIME 1.5GM (VIAL)
09/09/2025
09/15/2025
IV
650mg
Q8H
R/O Bowel Obstruction
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines